Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,36,0.97 [0.89-1.07],0.55325473883162
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,36,0.99 [0.95-1.02],0.493061609241006
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,36,0.98 [0.95-1.01],0.241411278749856
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,36,0.98 [0.92-1.05],0.624273094378809
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,36,0.99 [0.95-1.02],0.355179423650176
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,36,0.94 [0.61-1.44],0.773569416932969
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,36,0.98 [0.93-1.04],0.514124499652208
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,36,1.08 [1.00-1.16],0.0390422405784965
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,36,1.38 [0.80-2.39],0.247239311435005
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,Inverse variance weighted,36,1.05 [0.82-1.34],0.716294959833755
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,36,0.94 [0.88-1.01],0.0966091211186396
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,36,0.99 [0.94-1.05],0.841176215823793
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,36,1.10 [0.91-1.33],0.324510742490369
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",Inverse variance weighted,36,0.93 [0.77-1.13],0.466515478841597
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,36,1.03 [0.92-1.14],0.602027637040959
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,36,1.14 [0.95-1.37],0.149614410630719
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,36,1.03 [0.87-1.24],0.705916374697474
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,36,0.97 [0.90-1.05],0.460807645487886
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,36,0.98 [0.93-1.04],0.5963542979291
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,36,1.03 [0.91-1.17],0.588370230676384
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,Inverse variance weighted,36,0.86 [0.56-1.33],0.509721266041403
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,36,1.06 [0.83-1.34],0.642510862038692
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,36,1.02 [0.96-1.08],0.55864847639795
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,36,0.98 [0.93-1.03],0.471804801185923
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,Inverse variance weighted,36,1.11 [0.95-1.30],0.181808431881807
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,Inverse variance weighted,36,0.86 [0.70-1.05],0.133219163917435
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,36,1.04 [0.74-1.47],0.800302799972417
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,Inverse variance weighted,36,0.89 [0.78-1.02],0.0926299198309189
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,36,1.06 [0.97-1.16],0.227001490892437
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,Inverse variance weighted,36,0.94 [0.84-1.06],0.290382769373177
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,Inverse variance weighted,36,0.98 [0.73-1.30],0.868902809245784
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,36,1.09 [0.95-1.25],0.210174577319766
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,36,1.12 [1.02-1.23],0.0129342981603742
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,36,1.00 [0.90-1.12],0.968056301604051
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,36,1.03 [0.79-1.34],0.84206801344304
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,36,0.95 [0.83-1.09],0.491229792751967
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,36,0.93 [0.82-1.05],0.250966472778972
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,36,1.00 [0.88-1.13],0.991493599865628
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,36,1.03 [0.98-1.08],0.199249250786233
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",Inverse variance weighted,36,1.10 [0.98-1.23],0.11342538277955
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,36,0.81 [0.59-1.11],0.192560219119378
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,36,1.03 [0.97-1.10],0.368813199917163
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,36,1.04 [0.91-1.19],0.57007669876098
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,36,0.96 [0.82-1.12],0.593777433047499
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,36,0.96 [0.91-1.02],0.168201501649775
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,Inverse variance weighted,36,1.05 [0.77-1.45],0.748523653089943
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,36,0.99 [0.91-1.07],0.777100359805832
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,36,1.03 [0.94-1.15],0.507830356193841
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,36,1.08 [1.00-1.17],0.0555623958272777
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,36,0.99 [0.96-1.02],0.512300254279194
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,36,1.00 [0.97-1.03],0.96001447744583
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,36,0.83 [0.52-1.32],0.437329652681471
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,36,1.05 [0.93-1.19],0.446307658956189
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,36,1.00 [0.93-1.08],0.92767807499237
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,36,1.04 [0.63-1.74],0.871104777780811
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,36,1.06 [1.03-1.10],0.0001674458607175
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,36,0.97 [0.72-1.29],0.810750398431184
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,36,0.99 [0.88-1.10],0.797349415867073
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,36,0.95 [0.84-1.08],0.426390361925322
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,36,1.00 [0.97-1.04],0.910195608354155
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,36,1.02 [0.99-1.05],0.265785753466666
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,36,1.00 [0.98-1.03],0.796563213015808
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral cysts,Inverse variance weighted,36,1.03 [0.88-1.20],0.708019356987108
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,36,1.05 [0.95-1.16],0.349167615843268
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,Inverse variance weighted,36,0.96 [0.74-1.25],0.754626760570472
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,36,0.99 [0.96-1.01],0.281185330392577
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,36,1.07 [0.93-1.25],0.336418641122318
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other neurological diseases,Inverse variance weighted,36,0.96 [0.92-1.00],0.0699527919151454
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,36,0.99 [0.92-1.07],0.878275876911065
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,36,1.00 [0.93-1.09],0.940949382160217
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),Inverse variance weighted,36,1.03 [0.87-1.22],0.710292838551814
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,Inverse variance weighted,36,0.97 [0.85-1.10],0.637763606523464
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,Inverse variance weighted,36,0.99 [0.95-1.02],0.445482710016436
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),Inverse variance weighted,36,1.07 [0.95-1.19],0.255846800933132
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,36,0.98 [0.94-1.02],0.341969268661875
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,36,0.99 [0.96-1.03],0.762244874891946
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,Inverse variance weighted,36,1.01 [0.94-1.08],0.764158866688094
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,36,1.07 [0.89-1.28],0.500183442110525
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,36,0.96 [0.78-1.17],0.669319371425424
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,36,0.95 [0.84-1.08],0.446895438901583
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,36,0.98 [0.93-1.03],0.478203273973792
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,AV-block,Inverse variance weighted,36,1.05 [0.97-1.13],0.263500259521767
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,36,0.96 [0.82-1.12],0.618929106328071
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,36,1.03 [0.96-1.12],0.396349898286044
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",Inverse variance weighted,36,0.99 [0.88-1.11],0.826278266200985
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,36,1.03 [0.89-1.19],0.719786063218294
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,36,1.03 [0.99-1.08],0.162008545598484
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,36,1.03 [0.97-1.09],0.411126293818315
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,36,1.04 [1.00-1.08],0.0625208070718579
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,36,1.00 [0.96-1.04],0.979841710861918
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,36,1.03 [0.94-1.14],0.486510256992925
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,36,0.99 [0.96-1.02],0.425951564905221
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,36,0.99 [0.96-1.02],0.345590362176039
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,36,1.14 [0.78-1.66],0.507837003815861
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,36,1.01 [0.84-1.21],0.905775046666946
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,36,1.02 [0.98-1.06],0.26984516624925
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,36,0.98 [0.94-1.03],0.406669399168808
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,36,0.99 [0.87-1.13],0.895260541427113
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,36,1.06 [1.00-1.12],0.0350466693552974
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,Inverse variance weighted,36,1.05 [1.01-1.09],0.0160582178976821
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,36,1.06 [0.91-1.23],0.452180094112543
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,36,0.90 [0.75-1.08],0.260621260290686
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,36,0.94 [0.82-1.08],0.400398179941261
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,36,1.03 [0.97-1.10],0.343123329790323
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,Inverse variance weighted,36,1.07 [0.89-1.28],0.475368756560897
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,36,1.02 [0.96-1.08],0.572917492563246
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,36,0.98 [0.92-1.04],0.505965409079397
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,36,0.97 [0.80-1.16],0.711878166166217
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,36,0.94 [0.76-1.17],0.598127074970676
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,36,0.95 [0.78-1.16],0.595069345696602
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,36,1.02 [0.96-1.08],0.554571420734332
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,36,0.99 [0.95-1.03],0.675526157533288
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Varicose veins,Inverse variance weighted,36,0.99 [0.94-1.04],0.600511274335803
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,36,1.17 [0.94-1.45],0.169712536770799
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,36,1.01 [0.96-1.05],0.749895902190932
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,36,1.01 [0.91-1.13],0.799135389315138
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,36,0.98 [0.90-1.07],0.654119108010093
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,36,1.04 [0.88-1.23],0.607465486440515
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,36,0.93 [0.86-1.02],0.107880442833311
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,36,0.99 [0.93-1.04],0.65484696582038
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,36,0.91 [0.81-1.04],0.157949355677555
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,36,1.02 [0.89-1.18],0.77337964883064
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,36,0.89 [0.81-0.98],0.013708968032878
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,36,0.98 [0.92-1.05],0.638136371402891
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,36,1.02 [0.99-1.05],0.211888987117218
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,36,0.98 [0.94-1.02],0.360518421289024
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,36,0.93 [0.89-0.98],0.0026168121199846
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,36,0.97 [0.92-1.02],0.277559395759912
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,36,0.97 [0.89-1.06],0.52707636885749
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural plaque,Inverse variance weighted,36,0.96 [0.86-1.09],0.541689266235571
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,36,0.94 [0.83-1.07],0.349951950459026
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,36,1.01 [0.73-1.39],0.961959440407975
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Viral pneumonia,Inverse variance weighted,36,0.91 [0.81-1.01],0.0753478837431909
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,36,1.00 [0.96-1.04],0.85677137122328
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,36,1.12 [0.99-1.26],0.0626846899120322
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,36,0.96 [0.92-1.00],0.062318053482319
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Coeliac disease,Inverse variance weighted,36,1.08 [0.97-1.19],0.157349180596566
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,36,0.98 [0.94-1.02],0.294664389338624
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,Inverse variance weighted,36,0.97 [0.92-1.02],0.2457604095566
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,36,0.93 [0.86-1.01],0.0801838319089661
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,36,1.01 [0.97-1.04],0.676970640621549
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,36,1.03 [0.95-1.11],0.462933929373523
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,36,1.12 [0.97-1.30],0.114707988121517
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,Inverse variance weighted,36,1.01 [0.95-1.07],0.813299652582411
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,36,1.07 [0.86-1.33],0.54831348214208
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Hernia,Inverse variance weighted,36,1.01 [0.98-1.04],0.713693024913165
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,Inverse variance weighted,36,1.02 [0.95-1.09],0.622961742262327
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,36,1.01 [0.98-1.03],0.623824729604879
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,36,1.00 [0.94-1.06],0.99723616815652
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,Inverse variance weighted,36,1.12 [0.95-1.32],0.189127137835931
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophagitis,Inverse variance weighted,36,0.87 [0.74-1.03],0.105942644966787
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,36,0.98 [0.96-1.01],0.209439681927334
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,Inverse variance weighted,36,1.03 [0.97-1.09],0.330331923967188
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,36,1.02 [0.97-1.07],0.454707204672538
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,36,1.02 [0.96-1.08],0.503328428277525
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,Inverse variance weighted,36,0.96 [0.86-1.07],0.486918630715954
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,36,0.94 [0.82-1.08],0.396833436219839
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,36,1.01 [0.92-1.10],0.867158547363708
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,36,0.97 [0.92-1.02],0.281101249937142
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,36,0.99 [0.92-1.06],0.687772413530021
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",Inverse variance weighted,36,1.02 [0.94-1.10],0.63831434474067
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,36,1.03 [0.90-1.18],0.675841012137648
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,36,1.03 [0.91-1.15],0.668146278750298
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,36,1.06 [0.90-1.24],0.512761885207003
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,36,1.07 [0.92-1.23],0.383309740620246
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,Inverse variance weighted,36,1.03 [0.91-1.17],0.59780229637692
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,Inverse variance weighted,36,1.00 [0.97-1.04],0.874346042095879
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,Inverse variance weighted,36,0.90 [0.79-1.03],0.132964674803451
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,36,1.00 [0.98-1.03],0.748531829896338
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,36,1.00 [0.96-1.05],0.863824984711531
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,36,0.98 [0.90-1.07],0.60272537185731
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,36,0.88 [0.75-1.02],0.085532220187067
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,Inverse variance weighted,36,1.00 [0.95-1.05],0.976601898843874
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,36,1.03 [0.99-1.08],0.104449520890084
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,Inverse variance weighted,36,1.08 [0.82-1.43],0.597122854768679
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,Inverse variance weighted,36,0.94 [0.83-1.07],0.376883207058272
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,36,1.00 [0.96-1.04],0.995165890733404
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,36,1.00 [0.91-1.10],0.985916381921695
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,36,1.00 [0.98-1.03],0.787954012845555
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,36,0.98 [0.96-1.01],0.306661361584857
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,36,0.99 [0.94-1.05],0.786795305653366
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,Inverse variance weighted,36,0.91 [0.73-1.13],0.381257104491553
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,36,0.97 [0.95-0.99],0.0077096682375914
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,36,1.01 [0.94-1.08],0.798359768614795
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,Inverse variance weighted,36,1.01 [0.98-1.05],0.538355517236091
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,36,1.02 [0.97-1.07],0.481325653971634
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,Inverse variance weighted,36,0.97 [0.81-1.16],0.731031996629454
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,36,1.07 [0.99-1.15],0.0740342130363918
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,36,1.00 [0.97-1.03],0.943779619356178
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,36,1.04 [0.99-1.10],0.113055307977696
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,36,1.04 [0.95-1.14],0.361737234341875
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],Inverse variance weighted,36,1.10 [0.91-1.33],0.329800732840062
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,36,1.01 [0.99-1.03],0.537147776239181
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,36,1.05 [0.90-1.22],0.51873892029603
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,36,1.03 [0.99-1.06],0.10830022654008
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,36,0.97 [0.89-1.05],0.437547109186677
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,36,0.97 [0.80-1.18],0.783680403631135
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,36,0.99 [0.93-1.07],0.837980046081163
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,Inverse variance weighted,36,0.97 [0.83-1.13],0.702279825900138
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,36,1.27 [1.06-1.52],0.0101448170559443
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,36,1.16 [1.05-1.29],0.0050852411226433
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,36,0.99 [0.90-1.10],0.923026921488955
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,36,1.03 [0.94-1.14],0.502137932914773
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,36,1.03 [0.94-1.14],0.489001071344789
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,36,0.98 [0.81-1.19],0.839318848301354
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,36,0.95 [0.64-1.41],0.803868801016288
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,36,0.99 [0.96-1.03],0.765313065700008
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,36,0.98 [0.86-1.11],0.708611126569267
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,36,1.03 [0.90-1.18],0.696753555453361
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,Inverse variance weighted,36,1.01 [0.88-1.17],0.850362426946736
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,36,0.98 [0.95-1.02],0.333303399803076
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,36,0.98 [0.96-1.01],0.232875387966619
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,36,0.93 [0.82-1.05],0.241664468541766
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,36,1.04 [0.91-1.18],0.558348403169688
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,36,1.05 [0.94-1.17],0.393600356887288
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,Inverse variance weighted,36,1.02 [0.92-1.13],0.752561450791044
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",Inverse variance weighted,36,1.02 [0.92-1.13],0.711735131415988
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,Inverse variance weighted,36,0.95 [0.74-1.22],0.691998074624348
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,36,0.97 [0.86-1.10],0.635275501934365
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",Inverse variance weighted,36,0.84 [0.70-1.01],0.0583690434867698
